BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10212345)

  • 21. Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring.
    Ben-Dov IZ; Ben-Arie L; Mekler J; Bursztyn M
    Int J Cardiol; 2007 May; 117(3):355-9. PubMed ID: 16879886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. White coat hypertension in Zimbabwean African women.
    Bhagat K
    East Afr Med J; 2000 Aug; 77(8):452-5. PubMed ID: 12862073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. White-coat hypertension and autonomic nervous system dysregulation.
    Neumann SA; Jennings JR; Muldoon MF; Manuck SB
    Am J Hypertens; 2005 May; 18(5 Pt 1):584-8. PubMed ID: 15882538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between continuous ambulatory arterial blood pressure monitoring and standard blood pressure measurements among patients of younger and older age group.
    Babić BK; Bagatin J; Kokić S; Ostojić SB; Carević V; Berović N
    Coll Antropol; 2009 Mar; 33(1):65-70. PubMed ID: 19408605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of association between body-mass index and white-coat hypertension among referred patients.
    Ben-Dov IZ; Mekler J; Ben-Arie L; Bursztyn M
    Blood Press Monit; 2007 Apr; 12(2):95-9. PubMed ID: 17353652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White-coat hypertension: a clinical review.
    Celis H; Fagard RH
    Eur J Intern Med; 2004 Oct; 15(6):348-357. PubMed ID: 15522568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure on arising, morning blood pressure surge and blood pressure variability in white coat hypertensives and in matched normotensives and sustained hypertensives.
    Polónia J; Carvalho N; Barbosa L; Silva JA
    Rev Port Cardiol; 2006; 25(7-8):693-704. PubMed ID: 17069435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical significance of white-coat and masked hypertension.
    Verdecchia P; Angeli F; Gattobigio R; Borgioni C; Castellani C; Sardone M; Reboldi G
    Blood Press Monit; 2007 Dec; 12(6):387-9. PubMed ID: 18277317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. White-coat hypertension and sex.
    James GD; Marion R; Pickering TG
    Blood Press Monit; 1998 Oct; 3(5):281-287. PubMed ID: 10212367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Is prevalence of the "white coat effect" correlated with a high risk of late diabetic complications in type 2 diabetic patients?].
    Mozdzan M; Ruxer J; Barański M; Roszczyk N; Markuszewski L
    Ann Acad Med Stetin; 2008; 54(1):65-9; discussion 69. PubMed ID: 19127812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of ambulatory blood pressure.
    Imai Y
    Blood Press Monit; 1999 Oct; 4(5):249-56. PubMed ID: 10547646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Systolic-diastolic arterial hypertension versus isolated systolic hypertension].
    Giannuzzi P; Eleuteri E
    Ital Heart J; 2000 Jun; 1 Suppl 2():93-9. PubMed ID: 10905135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The difference between clinical ambulatory measured blood pressure and daily monitored pressure does not reflect the "white coat effect"].
    Santucciu C; Parati G; Ulian L; Omboni S; Mancia G
    Cardiologia; 1997 Oct; 42(10):1067-9. PubMed ID: 9534282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and clinical correlates of white coat hypertension in chronic kidney disease.
    Minutolo R; Borrelli S; Scigliano R; Bellizzi V; Chiodini P; Cianciaruso B; Nappi F; Zamboli P; Conte G; De Nicola L
    Nephrol Dial Transplant; 2007 Aug; 22(8):2217-23. PubMed ID: 17420167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein and B-type natriuretic peptides in never-treated white coat hypertensives.
    Conen D; Dieterle T; Utech K; Rimner M; Martina B
    Hypertens Res; 2006 Jun; 29(6):411-5. PubMed ID: 16940703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulse pressure is more susceptible to the white coat effect than is systolic blood pressure: observations from real-life ambulatory blood pressure monitoring.
    Ben-Dov IZ; Perk G; Ben-Arie L; Mekler J; Bursztyn M
    Am J Hypertens; 2004 Jun; 17(6):535-9. PubMed ID: 15177528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ambulatory blood pressure monitoring in clinical trials.
    Staessen J; Fagard R; Lijnen P; Thijs L; van Hoof R; Amery A
    J Hypertens Suppl; 1991 Jan; 9(1):S13-9. PubMed ID: 2040902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aortic elastic properties and left ventricular diastolic function in white-coat hypertensive individuals.
    Erdogan D; Caliskan M; Gullu H; Yildirim I; Ozer I; Ozgul A; Muderrisoglu H
    Blood Press Monit; 2006 Aug; 11(4):191-8. PubMed ID: 16810029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of blood pressure variability in essential hypertension.
    Verdecchia P; Borgioni C; Ciucci A; Gattobigio R; Schillaci G; Sacchi N; Santucci A; Santucci C; Reboldi G; Porcellati C
    Blood Press Monit; 1996 Feb; 1(1):3-11. PubMed ID: 10226196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.